№ lp_1_2_34874
File format: docx
Character count: 7583
File size: 138 KB
Year:
2024
Region / city:
Greater Manchester
Subject:
Dementia, Health Resources
Document Type:
Collated Resource Guide
Organization / Institution:
Dementia United
Author:
Dementia United, Jacqui Cannon, Lewy Body Society
Target audience:
People affected by dementia, carers, practitioners
Period of validity:
Ongoing (reviewed twice yearly)
Approval date:
October 2024
Modification date:
October 2024
Context:
Collated resources from external organizations aimed at providing information and support for those affected by young onset and rarer forms of dementia.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Acronym:
ABBRUPT
Organ / Institution:
University of Birmingham
Unit:
Birmingham Clinical Trials Unit (BCTU)
Trial Office:
ABBRUPT Trial Office
Country:
United Kingdom
Regulatory Framework:
UK Data Protection Regulations
Policy Framework:
UK Policy Framework for Health and Social Care Research
Trial Design:
Pragmatic open-label interventional multi-centre two-arm randomised controlled trial with internal pilot and economic evaluation
Objectives:
To compare clinical and cost effectiveness of beta blockers versus amiodarone for new onset atrial fibrillation in intensive care and to conduct cost-effectiveness and cost-utility analyses at 90-day follow-up
Target Population:
Patients aged 16 years and over in intensive care units with new onset atrial fibrillation
Sample Size:
2560 patients
Setting:
At least 60 intensive care units across the UK
Interventions:
Amiodarone versus beta blockers (including bisoprolol, metoprolol, esmolol, propranolol, atenolol, labetalol, carvedilol, landiolol)
Primary Outcome:
90-day mortality
Secondary Outcomes:
Clinical and economic outcomes including ICU and hospital measures
Eligibility Criteria:
Defined inclusion and exclusion criteria for patients with new onset atrial fibrillation in ICU
Data Management:
Contact details retained indefinitely on a BCTU database and subject to written request under UK Data Protection Regulations
Oversight Requirements:
Approval required from relevant Trust or Health Board Management prior to patient consent
Consent Requirements:
Written informed consent and participant information sheet on Trust/Health Board headed paper
Local Governance:
Compliance with Good Clinical Practice and UK Policy Framework for Health and Social Care Research
Document type:
Supplementary research tables and figure
Field of study:
Infectious diseases and clinical epidemiology
Topic:
Sepsis onset timing, bloodstream pathogens, and statistical analysis of clinical variables
Related condition:
Sepsis during the CIN window
Data scope:
Distribution of sepsis onset times from index time (T0; first CIN onset)
Sample size (sepsis cases):
48
Blood culture isolates analyzed:
31
Pathogen categories:
Gram-negative bacteria, Gram-positive bacteria, fungi
Key pathogens listed:
Escherichia coli; Pseudomonas aeruginosa; Viridans streptococci; Enterococcus spp; Staphylococcus aureus; Candida albicans
Statistical analysis:
Variance Inflation Factor (VIF) analysis after excluding CRP
Variables analyzed:
CAR, RDW, PLT, PCT, IL6, Oral mucosal status, Risk stratification
Figure description:
Missing data assessment for variables included in the analyses
Abbreviations defined:
CAR (C-reactive protein/albumin ratio); PCT (procalcitonin); RDW (red blood cell distribution width); PLT (platelet)
Year:
2023
Region / City:
United Kingdom
Topic:
Hormone replacement therapy, asthma, menopause
Document Type:
Research study
Organization / Institution:
University of Edinburgh, Asthma UK
Author:
Syed A Shah, Holly Tibble, Rebecca Pillinger, Susannah McLean, Dermot Ryan, Hilary Critchley, David Price, Catherine M Hawrylowicz, Colin R Simpson, Ireneous N Soyiri, Francis Appiagyei, Aziz Sheikh, Bright I Nwaru
Target Audience:
Researchers, healthcare professionals
Study Period:
1/1/2000 – 12/31/2016
Approval Date:
2023
Funding:
Asthma UK, Health Data Research UK
Conflicts of Interest:
No conflicts of interest declared
Methodology:
Longitudinal cohort study, multilevel Cox regression models
Conclusion Date:
2023
Year:
2023
Region / City:
Global
Topic:
Mental Health, Psychosis, Schizophrenia
Document Type:
Research Protocol / Search Strategy
Organization:
N/A
Author:
N/A
Target Audience:
Researchers, Mental Health Professionals
Effective Period:
N/A
Approval Date:
N/A
Revision Date:
N/A
Keywords:
psychosis, schizophrenia, risk, treatment, early intervention, qualitative research, search strategy
Year:
2021
Region / City:
International
Theme:
Obsessive-Compulsive Disorder, Age of Onset
Document Type:
Research Report
Target Audience:
Mental Health Professionals, Researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Number of Pages:
7
Number of References:
33
Number of Figures:
2
Number of Tables:
2
Clinical Trial Number:
Not available
Keywords:
Obsessive-compulsive disorder (OCD), age at onset (AAO), childhood-onset, adolescent-onset, adult-onset, cognitive behavioral therapy (CBT)
Contextual Description:
A clinical research report discussing the prevalence and clinical characteristics of OCD based on age at onset, comparing childhood, adolescent, and adult onset groups in an international multicenter study.